What is the Access Bio test offered by Concentric by Ginkgo?

The Access Bio test is a rapid antigen test. The test is authorized for use as a visually read lateral flow immunochromatographic assay for the detection of SARS-CoV-2 in nasopharyngeal swab specimens directly collected, or collected in BD universal transport media, from individuals suspected of COVID-19 by their healthcare provider within five days of symptom onset. The SARS-CoV-2 viral antigen is generally detectable in nasopharyngeal swab specimens during the acute phase of infection.

Important information about the Access Bio rapid antigen test can be found here:

FDA EUA Letter
Access Bio IFU
FDA HCP Fact Sheet
FDA Patient Fact Sheet